Open-label study of donepezil in chronic poststroke aphasia.

@article{Berthier2003OpenlabelSO,
  title={Open-label study of donepezil in chronic poststroke aphasia.},
  author={Marcelo Luis Berthier and Jul{\'i}an Hinojosa and Mar{\'i}a del Carmen Mart{\'i}n and Inmaculada Fern{\'a}ndez},
  journal={Neurology},
  year={2003},
  volume={60 7},
  pages={
          1218-9
        }
}
Donepezil hydrochloride (HCl), a reversible acetylcholinesterase inhibitor with a selective central action, is effective in ameliorating language and cognitive deficits in dementia of Alzheimer type.1 Preliminary clinical experience in single-case studies and small numbers of patients suggests that donepezil HCl may also stabilize cognitive deficits associated with subcortical vascular dementia2 and may improve language deficits in patients with post-stroke aphasia.3,4⇓ We studied donepezil HCl… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS

Aphasia and Apraxia Evidence Tables

VIEW 13 EXCERPTS
HIGHLY INFLUENCED

Pharmacotherapy in stroke rehabilitation.

  • Expert opinion on pharmacotherapy
  • 2009
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Aphasia and Apraxia

VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-8 OF 8 REFERENCES

Pharmacotherapy of aphasia. Neurology 1988;38:877–879

ML Albert, D Bachman, A Morgan, N. Helm-Estabrooks
  • NEUROLOGY
  • 2003

Effects of donepezil on aphasia, agnosia, and apraxia in patients with cerebrovascular lesions [abstract

C Tsz-Ming, DJ Kaufer
  • J Neuropsychiatry Clin Neurosci
  • 2001

Donepezil for mild and moderate Alzheimer's disease.

  • The Cochrane database of systematic reviews
  • 2000

Pharmacother - apy of aphasia

ML Albert, D Bachman, A Morgan, N Helm-Estabrooks
  • Neurology
  • 1988